{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:14:41Z","timestamp":1793499281362,"version":"4.5.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T00:00:00Z","timestamp":1391558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s11102-014-0556-y","type":"journal-article","created":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T15:54:15Z","timestamp":1391529255000},"page":"48-59","source":"Crossref","is-referenced-by-count":33,"title":["Discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly: a stepwise approach and management"],"prefix":"10.1007","volume":"18","author":[{"given":"Mehdi","family":"Zeinalizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Fernandez-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Hodak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue M.","family":"Challinor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,5]]},"reference":[{"key":"556_CR1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1210\/jc.2008-1371","volume":"94","author":"JD Carmichael","year":"2009","unstructured":"Carmichael JD, Bonert VS, Mirocha JM, Melmed S (2009) The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. J Clin Endocrinol Metab 94:523\u2013527","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR2","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"S Melmed","year":"2006","unstructured":"Melmed S (2006) Medical progress: acromegal. N Engl J Med 355:2558\u20132573","journal-title":"N Engl J Med"},{"key":"556_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2265.1980.tb03135.x","volume":"12","author":"L Alexander","year":"1980","unstructured":"Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R (1980) Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol 12:71\u201379","journal-title":"Clin Endocrinol"},{"key":"556_CR4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ghir.2010.09.003","volume":"20","author":"T Wu","year":"2010","unstructured":"Wu T, Lin H, Lu R, Wang M, Chen R, Chen H (2010) The role of insulin-like growth factor-1 and growth hormone in the mortality of patients with acromegaly after trans-sphenoidal surgery. Growth Horm IGF Res 20:411\u2013415","journal-title":"Growth Horm IGF Res"},{"issue":"1","key":"556_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1009965803750","volume":"2","author":"IM Holdaway","year":"1999","unstructured":"Holdaway IM, Rajasoorya C (1999) Epidemiology of acromegaly. Pituitary 2(1):29\u201341","journal-title":"Pituitary"},{"key":"556_CR6","doi-asserted-by":"crossref","unstructured":"Fleseriu M, Delashaw JB, Jr, Cook DM (2010) Acromegaly: a review of current medical therapy and new drugs on the horizon. Neurosurg Focus E15. doi: 10.3171\/2010.7.FOCUS10154","DOI":"10.3171\/2010.7.FOCUS10154"},{"issue":"3","key":"556_CR7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4158\/EP.10.3.213","volume":"10","author":"DM Cook","year":"2004","unstructured":"Cook DM, Ezzat S, Katznelson L, Kleinberg DL, Laws ER Jr, Nippoldt TB, Swearingen B, Vance ML (2004) AACE medical guidelines for clinical practice for the diagnosis and treatment of acromegaly. Endocr Pract 10(3):213\u2013225","journal-title":"Endocr Pract"},{"key":"556_CR8","first-page":"3419","volume":"83","author":"B Swearingen","year":"1998","unstructured":"Swearingen B, Barker FG, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419\u20133426","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR9","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1210\/jc.2004-1797","volume":"89","author":"DR Clemmons","year":"2004","unstructured":"Clemmons DR, Strasburger C (2004) Monitoring the response to treatment in acromegaly. J Clin Endocrinol Metab 89:5289\u20135291","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"556_CR10","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.2009-2670","volume":"95","author":"A Giustina","year":"2010","unstructured":"Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95(7):3141\u20133148","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR11","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1210\/jc.2007-2084","volume":"93","author":"AM Arafat","year":"2008","unstructured":"Arafat AM, M\u00f6hlig M, Weickert MO, Perschel FH, Purschwitz J, Spranger J, Strasburger CJ, Sch\u00f6fl C, Pfeiffer AF (2008) Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J Clin Endocrinol Metab 93:1254\u20131262","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR12","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1210\/jcem.86.4.7398","volume":"86","author":"GA Kaltsas","year":"2001","unstructured":"Kaltsas GA, Isidori AM, Florakis D, Trainer PJ, Camacho-Hubner C, Afshar F, Sabin I, Jenkins JP, Chew SL, Monson JP, Besser GM, Grossman AB (2001) Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. J Clin Endocrinol Metab 86:1645\u20131652","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2265.2004.02064.x","volume":"6","author":"F Minuto","year":"2004","unstructured":"Minuto F, Resmini E, Boschetti M, Arvigo M, Sormani MP, Giusti M, Ferone D, Barreca A (2004) Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system. Clin Endocrinol 6:138\u2013144","journal-title":"Clin Endocrinol"},{"key":"556_CR14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ecl.2006.11.008","volume":"36","author":"DR Clemmons","year":"2007","unstructured":"Clemmons DR (2007) Value of insulin-like growth factor system markers in the assessment of growth hormone status. Endocrinol Metab Clin North Am 36:109\u2013129","journal-title":"Endocrinol Metab Clin North Am"},{"key":"556_CR15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1055\/s-0029-1239522","volume":"42","author":"PCL Elias","year":"2010","unstructured":"Elias PCL, Lugao HB, Pereira M, Machado HR, de Castro M, Moreira AC (2010) Discordant nadir GH after oral glucose and IGF-ilevels on treated acromegaly: refining the biochemical markers of mild disease activity. Horm Metab Res 42:50\u201355","journal-title":"Horm Metab Res"},{"key":"556_CR16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2265.1994.tb03787.x","volume":"41","author":"KY Ho","year":"1994","unstructured":"Ho KY, Weissberger AJ (1994) Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy. Clin Endocrinol 41:75\u201383","journal-title":"Clin Endocrinol"},{"key":"556_CR17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1210\/jcem.80.12.8530632","volume":"80","author":"M Semer","year":"1995","unstructured":"Semer M, Faria AC, Nery M, Salgado LR, Knoepfelmacher M, Wajchenberg BL, Liberman B (1995) Growth hormone pulsatility in active and cured acromegaly subjects. J Clin Endocrinol Metab 80:767\u20133770","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1096-6374(03)00029-7","volume":"13","author":"PU Freda","year":"2003","unstructured":"Freda PU (2003) Current concepts in the biochemical assessment of the patient with acromegaly. Growth Horm IGF Res 13:171\u2013184","journal-title":"Growth Horm IGF Res"},{"key":"556_CR19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2265.1999.00615.x","volume":"50","author":"E Duncan","year":"1999","unstructured":"Duncan E, Wass JAH (1999) Investigation protocol: acromegaly and its Investigation. Clin Endocrinol 50:285\u2013293","journal-title":"Clin Endocrinol"},{"key":"556_CR20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s11102-011-0369-1","volume":"15","author":"JA Brzana","year":"2012","unstructured":"Brzana JA, Yedinak CG, Delashaw JB, Gultelkin HS, Cook D, Fleseriu M (2012) Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly na\u00efve to medical therapy and radiation: what to follow, GH or IGF-1 values? Pituitary 15:562\u2013570","journal-title":"Pituitary"},{"key":"556_CR21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1258\/0004563011900678","volume":"38","author":"SR Peacey","year":"2001","unstructured":"Peacey SR, Shalet SM (2001) Insulin-like growth factor 1 measurement in diagnosis and management of acromegaly. Ann Clin Biochem 38:297\u2013303","journal-title":"Ann Clin Biochem"},{"key":"556_CR22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2265.2009.03578.x","volume":"71","author":"N Karavitaki","year":"2009","unstructured":"Karavitaki N, Fernandez A, Fazal-Sanderson V, Wass JAH (2009) The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly. Clin Endocrinol 71:840\u2013845","journal-title":"Clin Endocrinol"},{"key":"556_CR23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2265.1995.tb02651.x","volume":"42","author":"AS Bates","year":"1995","unstructured":"Bates AS, Evans AJ, Jones P, Clayton RN (1995) Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion. Clin Endocrinol 42:417\u2013423","journal-title":"Clin Endocrinol"},{"key":"556_CR24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2265.1993.tb02139.x","volume":"38","author":"RD Dobrashian","year":"1993","unstructured":"Dobrashian RD, O\u2019Halloran DJ, Hunt A, Beardwell CG, Shalet SM (1993) Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Clin Endocrinol 38:589\u2013593","journal-title":"Clin Endocrinol"},{"issue":"1","key":"556_CR25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2265.2008.03461.x","volume":"71","author":"M Sherlock","year":"2009","unstructured":"Sherlock M, Aragon Alonso A, Reulen RC, Ayuk J, Clayton RN, Holder G, Sheppard MC, Bates A, Stewart PM (2009) Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly. Clin Endocrinol 71(1):74\u201381","journal-title":"Clin Endocrinol"},{"key":"556_CR26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11102-011-0310-7","volume":"14","author":"A Ben-Shlomo","year":"2011","unstructured":"Ben-Shlomo A, Sheppard MC, Stephens JM, Pulgar S, Melmed S (2011) Clinical, quality of life, and economic value of acromegaly disease control. Pituitary 14:284\u2013294","journal-title":"Pituitary"},{"key":"556_CR27","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1210\/jcem.86.11.8006","volume":"86","author":"C Parkinson","year":"2001","unstructured":"Parkinson C, Ryder WDJ, Trainer PJ (2001) The relationship between serum GH and serum IGF-I in acromegaly is gender-specific. J Clin Endocrinol Metab 86:5240\u20135244","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000082032","volume":"62","author":"M Mercado","year":"2004","unstructured":"Mercado M, Espinosa de los Monteros AL, Sosa E, Cheng S, Mendoza V, Hern\u00e1ndez I, Sandoval C, Guinto G, Molina M (2004) Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease. Horm Res 62:293\u2013299","journal-title":"Horm Res"},{"issue":"12","key":"556_CR29","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1210\/jc.2005-0901","volume":"90","author":"R Feelders","year":"2005","unstructured":"Feelders R, Bidlingmaier M, Strasburger CJ, Janssen JA, Uitterlinden P, Hofland LJ, Lamberts SW, van der Lely AJ, de Herder WW (2005) Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels. J Clin Endocrinol Metab 90(12):6480\u20136489","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11102-007-0036-8","volume":"10","author":"AM Brooke","year":"2007","unstructured":"Brooke AM, Drake WM (2007) Serum IGF-I levels in the diagnosis and monitoring of acromegaly. Pituitary 10:173\u2013179","journal-title":"Pituitary"},{"key":"556_CR31","first-page":"4193","volume":"85","author":"R Dall","year":"2000","unstructured":"Dall R, Longobardi S, Ehrnborg C, Keay N, Rosen T, Jorgensen JO, Cuneo RC, Boroujerdi MA, Cittadini A, Napoli R, Christiansen JS, Bengtsson BA, Sacca L, Baxter RC, Basset EE, Sonksen PH (2000) The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 study group. J Clin Endocrinol Metab 85:4193\u20134200","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR32","first-page":"3808","volume":"83","author":"PU Freda","year":"1998","unstructured":"Freda PU, Post KD, Powell JS, Wardlaw SL (1998) Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. J Clin Endocrinol Metab 83:3808\u20133816","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR33","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1210\/jcem.87.7.8631","volume":"87","author":"AC Costa","year":"2002","unstructured":"Costa AC, Rossi A, MartinelliJr CE, Machado HR, Moreira AC (2002) Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure? J Clin Endocrinol Metab 87:3142\u20133147","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR34","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1210\/jcem.87.5.8509","volume":"87","author":"BM Biller","year":"2002","unstructured":"Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML (2002) Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 87:2067\u20132079","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"556_CR35","first-page":"1","volume":"2013","author":"KL Edling","year":"1994","unstructured":"Edling KL, Heaney AP (1994) An update on the treatment of acromegaly. Res Rep Endocr Disord 2013(3):1\u201311","journal-title":"Res Rep Endocr Disord"},{"key":"556_CR36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/EJE-10-0744","volume":"164","author":"A Ribeiro-Oliveira Jr","year":"2011","unstructured":"Ribeiro-Oliveira A Jr, Faje AT, Barkan AL (2011) Limited utility of oral glucose tolerance test in biochemically active acromegaly. Eur J Endocrinol 164:17\u201322","journal-title":"Eur J Endocrinol"},{"key":"556_CR37","doi-asserted-by":"crossref","unstructured":"Pl\u00f6ckinger U (2012) Medical therapy of acromegaly. Int J Endocrinol. doi: 10.1155\/2012\/268957","DOI":"10.1155\/2012\/268957"},{"key":"556_CR38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2265.2012.04346.x","volume":"76","author":"SJCMM Neggers","year":"2012","unstructured":"Neggers SJCMM, Biermasz NR, van der Lely AJ (2012) What is active acromegaly and which parameters do we have? Clin Endocrinol 76:609\u2013614","journal-title":"Clin Endocrinol"},{"key":"556_CR39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1210\/jc.2003-031316","volume":"89","author":"PU Freda","year":"2004","unstructured":"Freda PU, Nuruzzaman AT, Reyes CM, Sundeen RE, Post KD (2004) Significance of \u201cabnormal\u201d nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. J Clin Endocrinol Metab 89:495\u2013500","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR40","first-page":"191","volume":"11","author":"S Hepburn","year":"2006","unstructured":"Hepburn S, Chambers SM, Gilbert JA, McGregor AM, Miell JP, Aylwin SJB (2006) Concordance between GH determination and IGF-I in acromegaly using two IGF-I methods. Endocr Abstracts 11:191","journal-title":"Endocr Abstracts"},{"key":"556_CR41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1530\/eje.0.1500465","volume":"150","author":"S Gullu","year":"2004","unstructured":"Gullu S, Keles H, Delibasi T, Tonyukuk V, Kamel N, Erdogan G (2004) Remission criteria for the follow-up of patients with acromegaly. Eur J Endocrinol 150:465\u2013471","journal-title":"Eur J Endocrinol"},{"key":"556_CR42","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1373\/clinchem.2005.060236","volume":"52","author":"H Markkanen","year":"2006","unstructured":"Markkanen H, Pekkarinen T, Valimaki MJ, Alfthan H, Kauppinen-Makelin R, Sane T, Stenman UH (2006) Effect of sex and assay method on serum concentrations of growth hormone in patients with acromegaly and in healthy controls. Clin Chem 52:468\u2013473","journal-title":"Clin Chem"},{"key":"556_CR43","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/BF03345496","volume":"25","author":"A Colao","year":"2002","unstructured":"Colao A, Amato G, Pedroncelli AM, Baldelli R, Grottoli S, Gasco V, Petretta M, Carella C, Pagani G, Tambura G, Lombardi G (2002) Gender- and age-related differences in the endocrine parameters of acromegaly. J Endocrinol Invest 25:532\u2013538","journal-title":"J Endocrinol Invest"},{"key":"556_CR44","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1210\/jc.2007-2084","volume":"93","author":"AM Arafat","year":"2008","unstructured":"Arafat AM, M\u00f6hlig M, Weickert MO, Perschel FH, Purschwitz J, Spranger J, Strasburger CJ, Sch\u00f6fl C, Pfeiffer AFH (2008) Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J Clin Endocrinol Metab 93:1254\u20131262","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR45","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cca.2006.05.027","volume":"373","author":"C Massart","year":"2006","unstructured":"Massart C, Poirier JY (2006) Serum insulin-like growth factor-I measurement in the follow-up of treated acromegaly: comparison of four immunoassays. Clin Chim Acta 373:176\u2013179","journal-title":"Clin Chim Acta"},{"key":"556_CR46","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1373\/clinchem.2010.150631","volume":"57","author":"DR Clemmons","year":"2011","unstructured":"Clemmons DR (2011) Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem 57:555\u2013559","journal-title":"Clin Chem"},{"key":"556_CR47","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1210\/jcem.87.8.8658","volume":"87","author":"EV Dimaraki","year":"2002","unstructured":"Dimaraki EV, Jaffe CA, Mott-Friberg R, Chandler WF, Barkan AL (2002) Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. J Clin Endocrinol Metab 87:3537\u20133542","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR48","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s11102-011-0351-y","volume":"15","author":"L Boero","year":"2012","unstructured":"Boero L, Manavela M, Danilowicz K, Alfieri A, Ballarino MC, Chervin A, Garc\u0131\u2032a-Basavilbaso N, Glerean M, Guitelman M, Loto MG, Nahm\u0131\u2032as JA, Rogozinski AS, Servidio M, Vitale NM, Katz D, Day PF, Stalldecker G, Mallea-Gil MS (2012) Comparison of two immunoassays in the determination of IGF-I levels and its correlation with oral glucose tolerance test (OGTT) and with clinical symptoms in acromegalic patients. Pituitary 15:466\u2013471","journal-title":"Pituitary"},{"key":"556_CR49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/B:PITU.0000023424.72021.e2","volume":"6","author":"PU Freda","year":"2003","unstructured":"Freda PU, Reyes CM, Nuruzzaman AT, Sundeen RE, Bruce JN (2003) Basal and glucose-suppressed GH levels less than 1 microg\/L in newly diagnosed acromegaly. Pituitary 6:175\u2013180","journal-title":"Pituitary"},{"key":"556_CR50","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1507\/endocrj.K06-083","volume":"54","author":"DJ Lim","year":"2007","unstructured":"Lim DJ, Kwon HS, Cho JH, Kim SH, Choi YH, Yoon KH, Cha BY, Lee KW, Son HY, Kang SK (2007) Acromegaly associated with type 2 diabetes showing normal IGF-1 levels under poorly controlled glycemia. Endocr J 54:537\u2013541","journal-title":"Endocr J"},{"key":"556_CR51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11102-011-0313-4","volume":"15","author":"FM Minuto","year":"2012","unstructured":"Minuto FM, Resmini E, Boschetti M, Rebora A, Fazzuoli L, Arvigo M, Giusti M, Ferone D (2012) Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. Pituitary 15:215\u2013221","journal-title":"Pituitary"},{"key":"556_CR52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ghir.2008.02.001","volume":"18","author":"EO Machado","year":"2008","unstructured":"Machado EO, Taboada GF, Neto LV, Van Haute FR, Corr\u00eaa LL, Balarini GA, Shrank Y, Goulart M, Gadelha MR (2008) Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR. Growth Horm IGF Res 18:389\u2013393","journal-title":"Growth Horm IGF Res"},{"key":"556_CR53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/eje.0.1410145","volume":"141","author":"I Halperin","year":"1999","unstructured":"Halperin I, Casamitjana C, Flores L, Fernandez-Balsells M, Vilardell E (1999) The role of IGF binding protein-3 as a parameter of activity in acromegalic patients. Eur J Endocrinol 141:145\u2013148","journal-title":"Eur J Endocrinol"},{"key":"556_CR54","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3171\/jns.2002.97.2.0287","volume":"97","author":"AL Espinosa-de-los-Monteros","year":"2002","unstructured":"Espinosa-de-los-Monteros AL, Mercado M, Sosa E, Lizama O, Guinto G, Lopez-Felix B, Garcia O, Hernandez I, Ovalle A, Mendoza V (2002) Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly. J Neurosurg 97:287\u2013292","journal-title":"J Neurosurg"},{"key":"556_CR55","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1677\/erc.0.0100611","volume":"10","author":"G Minniti","year":"2003","unstructured":"Minniti G, Jaffrain-Rea ML, Esposito V, Santoro A, Tamburrano G, Cantore G (2003) Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature. Endocr Relat Cancer 10:611\u2013619","journal-title":"Endocr Relat Cancer"},{"key":"556_CR56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/meta.2003.50036","volume":"52","author":"H Vierhapper","year":"2003","unstructured":"Vierhapper H, Heinze G, Gessl A, Exner M, Bieglmayr C (2003) Use of the oral glucose tolerance test to define remission in acromegaly. Metabolism 52:181\u2013185","journal-title":"Metabolism"},{"key":"556_CR57","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2265.2006.02430.x","volume":"64","author":"AL Espinosa-de-Los-Monteros","year":"2006","unstructured":"Espinosa-de-Los-Monteros AL, Sosa E, Cheng S, Ochoa R, Sandoval C, Guinto G, Mendoza V, Hernandez I, Molina M, Mercado M (2006) Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status. Clin Endocrinol 64:245\u2013249","journal-title":"Clin Endocrinol"},{"key":"556_CR58","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1210\/jc.2007-2104","volume":"93","author":"O Alexopoulou","year":"2008","unstructured":"Alexopoulou O, Bex M, Abs R, T\u2019Sjoen G, Velkeniers B, Maiter D (2008) Divergence between growth hormone and insulin-like growthfactor-1 concentrations in the follow-up of acromegaly. J Clin Endocrinol Metab 93:1324\u20131330","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR59","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1210\/jc.2008-1337","volume":"94","author":"A Bianchi","year":"2009","unstructured":"Bianchi A, Giustina A, Cimino V, Pola R, Angelini F, Pontecorvi A, De Marinis L (2009) Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. J Clin Endocrinol Metab 94:2015\u20132022","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"556_CR60","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1210\/jc.2011-0554","volume":"96","author":"JA Jane","year":"2011","unstructured":"Jane JA, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO, Marshall JC, Laws ER Jr, Vance ML (2011) Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab 96(9):2732\u20132740","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR61","first-page":"252","volume":"28","author":"N Scally","year":"2012","unstructured":"Scally N, Swords F, Gorick S, Chipchase A, Temple R (2012) Discordance between growth hormone and IGF1 in patients with acromegaly following recent guidelines. Endocr Abstracts 28:252","journal-title":"Endocr Abstracts"},{"key":"556_CR62","author":"SS Shin","year":"2012","unstructured":"Shin SS, Tormenti MJ, Paluzzi A, Rothfus WE, Chang YF, Zainah H, Fernandez-Miranda JC, Snyderman CH, Challinor SM, Gardner PA (2012) Gardner Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission. Pituitary. doi: 10.1007\/s11102-012-0440-6","journal-title":"Pituitary"},{"key":"556_CR63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2265.2009.03556.x","volume":"71","author":"PU Freda","year":"2009","unstructured":"Freda PU (2009) Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clin Endocrinol 71:166\u2013170","journal-title":"Clin Endocrinol"},{"key":"556_CR64","first-page":"3187","volume":"82","author":"AL Barkan","year":"1997","unstructured":"Barkan AL, Halasz I, Dornfeld KJ, Jaffe CA, Friberg RD, Chandler WF, Sandler HM (1997) Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab 82:3187\u20133191","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"556_CR65","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000063468","volume":"55","author":"O Isaksson","year":"2001","unstructured":"Isaksson O, Jansson J, Sjogren K, Ohlsson C (2001) Metabolic functions of liver-derived (endocrine) insulin-like growth factor-I. Horm Res 55(Suppl 1):18\u201321","journal-title":"Horm Res"},{"key":"556_CR66","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/BF03343879","volume":"24","author":"S Rojdmark","year":"2001","unstructured":"Rojdmark S, Brismar K (2001) Decreased IGF-I bioavailability after ethanol abuse in alcoholics: partial resolution after short term abstinence. J Endocrinol Invest 24:476\u2013482","journal-title":"J Endocrinol Invest"},{"key":"556_CR67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-10-0969","volume":"164","author":"SJ Neggers","year":"2011","unstructured":"Neggers SJ, Kopchick JJ, Jorgensen JO, van der Lely AJ (2011) Hypothesis: extra-hepatic acromegaly: a new paradigm? Eur J Endocrinol 164:11\u201316","journal-title":"Eur J Endocrinol"},{"key":"556_CR68","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF01453697","volume":"5","author":"W Blum","year":"1991","unstructured":"Blum W, Ranke M, Kietzmann K, Tonshoff B, Mehls O (1991) Growth hormone resistance and inhibition of somatomedin activity by excess insulin-like growth factor binding protein in uraemia. Paediatr Nephrol 5:539\u2013544","journal-title":"Paediatr Nephrol"},{"key":"556_CR69","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jcem-55-5-999","volume":"55","author":"T Merimee","year":"1982","unstructured":"Merimee T, Zapf J, Froesch E (1982) Insulin-like growth factors in the fed and fasted states. J Clin Endocrinol Metab 55:999\u20131002","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR70","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/er.2003-0035","volume":"25","author":"KC Leung","year":"2004","unstructured":"Leung KC, Johannsson G, Leong GM, Ho KKY (2004) Estrogen regulation of growth hormone action. Endocr Rev 25:693\u2013721","journal-title":"Endocr Rev"},{"key":"556_CR71","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/EJE-09-0053","volume":"161","author":"P Kamenicky","year":"2009","unstructured":"Kamenicky P, Santos CD, Espinosa C, Salenave S, Galland F, Bouc YL, Maison P, Bougn\u00e8res P, Chanson P (2009) GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly. Eur J Endocrinol 161:231\u2013235","journal-title":"Eur J Endocrinol"},{"key":"556_CR72","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/jcem-72-2-374","volume":"72","author":"AJ Weissberger","year":"1991","unstructured":"Weissberger AJ, Ho KK, Lazarus L (1991) Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72:374\u2013381","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR73","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2265.1992.tb02270.x","volume":"36","author":"AC Faria","year":"1992","unstructured":"Faria AC, Bekenstein LW, Booth RA Jr, Vaccaro VA, Asplin CM, Veldhuis JD, Thorner MO, Evans WS (1992) Pulsatile growth hormone release in normal women during the menstrual cycle. Clin Endocrinol 36:591\u2013596","journal-title":"Clin Endocrinol"},{"key":"556_CR74","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/jcem.83.5.4761","volume":"83","author":"P Ovesen","year":"1992","unstructured":"Ovesen P, Vahl N, Fisker S, Veldhuis JD, Christiansen JS, Jorgensen JO (1992) Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women. J Clin Endocrinol Metab 83:1662\u20131667","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR75","doi-asserted-by":"crossref","first-page":"E521","DOI":"10.1210\/jc.2011-3347","volume":"97","author":"V Birzniece","year":"2012","unstructured":"Birzniece V, Sutanto S, Ho KKY (2012) Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators. J Clin Endocrinol Metab 97:E521\u2013E527","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR76","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1210\/jcem-70-6-1678","volume":"70","author":"LM Winer","year":"1990","unstructured":"Winer LM, Shaw MA, Baumann G (1990) Basal plasma growth hormone levels in man: new evidence for rhthymicity of growth hormone secretion. J Clin Endocrinol Metab 70:1678\u20131686","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR77","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2265.2010.03896.x","volume":"74","author":"A Colao","year":"2011","unstructured":"Colao A, Pivonello R, Auriemma RS, Grasso LFS, Galdiero M, Pivonello C, Lombardi G, Savastano S (2011) Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects. Clin Endocrinol 74:234\u2013240","journal-title":"Clin Endocrinol"},{"issue":"1","key":"556_CR78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ghir.2009.09.005","volume":"20","author":"M Bidlingmaier","year":"2010","unstructured":"Bidlingmaier M, Freda PU (2010) Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences. Growth Horm IGF Res 20(1):19\u201325","journal-title":"Growth Horm IGF Res"},{"issue":"1","key":"556_CR79","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1210\/jcem.86.1.7154","volume":"86","author":"SR Peacey","year":"2001","unstructured":"Peacey SR, Toogood AA, Veldhuis JD, Thorner MO, Shalet SM (2001) The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy. J Clin Endocrinol Metab 86(1):259\u2013266","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1096-6374(03)00030-3","volume":"13","author":"IM Holdaway","year":"2003","unstructured":"Holdaway IM, Rajasoorya CR, Gamble GP, Stewart AW (2003) Long term treatment outcome in acromegaly. Growth Horm IGF Res 13:185\u2013192","journal-title":"Growth Horm IGF Res"},{"key":"556_CR81","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1530\/EJE-08-0243","volume":"159","author":"K Tanimoto","year":"2008","unstructured":"Tanimoto K, Hizuka N, Fukuda I, Takano K, Hanafusa T (2008) The influence of age on the GH\u2013IGF1 axis in patients with acromegaly. Eur J Endocrinol 159:375\u2013379","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"556_CR82","first-page":"3001","volume":"86","author":"P Marzullo","year":"2001","unstructured":"Marzullo P, Di Somma C, Pratt K, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG (2001) Usefulness of different biochemical markers of the insulin-like growth factor family in diagnosing growth hormone excess and deficiency in adults. J Clin Endocrinol Metab 86(7):3001\u20133008","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR83","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1210\/jc.2003-030110","volume":"88","author":"R Cozzi","year":"2003","unstructured":"Cozzi R, Attanasio R, Montini M, Pagani G, Lasio G, Lodrini S, Barausse M, Albizzi M, Dallabonzana D, Pedroncelli AM (2003) Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results? J Clin Endocrinol Metab 88:3090\u20133098","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR84","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF03345170","volume":"26","author":"CL Boguszewski","year":"2003","unstructured":"Boguszewski CL (2003) Molecular heterogeneity of human growth hormone from basic research to clinical applications. J Endocrinol Invest 26:274\u2013288","journal-title":"J Endocrinol Invest"},{"key":"556_CR85","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1210\/edrv-12-4-424","volume":"12","author":"G Baumann","year":"1991","unstructured":"Baumann G (1991) Growth hormone heterogeneity: genes, isohormones, variants and binding proteins. Endocr Rev 12:424\u2013429","journal-title":"Endocr Rev"},{"issue":"5","key":"556_CR86","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1210\/jc.2003-032150","volume":"89","author":"D Milani","year":"2004","unstructured":"Milani D, Carmichael JD, Welkowitz J, Ferris S, Reitz RE, Danoff A, Kleinberg DL (2004) Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development. J Clin Endocrinol Metab 89(5):2271\u20132274","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR87","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1530\/EJE-11-0098","volume":"164","author":"M Matta","year":"2011","unstructured":"Matta M, Bongard V, Grunenwald S, Maiza JC, Bennet A, Caron P (2011) Clinical and metabolic characteristics of acromegalic patients with high IGF1\/normal GH levels during somatostatin analog treatment. Eur J Endocrinol 164:885\u2013889","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"556_CR88","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1210\/jc.2008-0391","volume":"93","author":"M Mercado","year":"2008","unstructured":"Mercado M, Gonz\u00e1lez B, Sandoval C, Esquenazi Y, Mier F, Vargas G, de los Monteros AL, Sosa E (2008) Clinical and biochemical impact of the d3 growth factor receptor genotype in acromegaly. J Clin Endocrinol Metab 93(3):3411\u20133415","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR89","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/B:PITU.0000011174.79946.10","volume":"6","author":"PU Freda","year":"2003","unstructured":"Freda PU (2003) Pitfalls in the biochemical assessment of acromegaly. Pituitary 6:135\u2013140","journal-title":"Pituitary"},{"key":"556_CR90","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2265.2002.01560.x","volume":"57","author":"C Parkinson","year":"2002","unstructured":"Parkinson C, Renehan AG, Ryder WD, O\u2019Dwyer ST, Shalet SM, Trainer PJ (2002) Gender and age influence the relationship between serum GH and IGF-Iin patients with acromegaly. Clin Endocrinol 57:363\u2013370","journal-title":"Clin Endocrinol"},{"key":"556_CR91","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2265.1991.tb03766.x","volume":"34","author":"JM Holly","year":"1991","unstructured":"Holly JM, Cotterill AM, Jemmott RC, Shears D, Al-Othman S, Chard T, Wass JA (1991) Inter-relations between growth hormone, insulin, insulin-like growth factor-I (IGF-I), IGF-binding protein-1 (IGFBP-1) and sex hormone-bindingglobulin in acromegaly. Clin Endocrinol 34:275\u2013280","journal-title":"Clin Endocrinol"},{"key":"556_CR92","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","volume":"93","author":"OM Dekkers","year":"2008","unstructured":"Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP (2008) Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 93:61\u201367","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR93","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-08-0267","volume":"159","author":"IM Holdaway","year":"2008","unstructured":"Holdaway IM, Bolland MJ, Gamble GD (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol 159:89\u201395","journal-title":"Eur J Endocrinol"},{"key":"556_CR94","first-page":"526","volume":"85","author":"A Giustina","year":"2000","unstructured":"Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Werger KV, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526\u2013529","journal-title":"J Clin Endocrinol Metab"},{"issue":"11 Suppl Intern","key":"556_CR95","first-page":"75","volume":"28","author":"MC Sheppard","year":"2005","unstructured":"Sheppard MC (2005) GH and mortality in acromegaly. J Endocrinol Invest 28(11 Suppl International):75\u201377","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"556_CR96","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11102-011-0308-1","volume":"14","author":"ME Sughrue","year":"2011","unstructured":"Sughrue ME, Chang EF, Gabriel RA, Aghi MK, Blevins LS (2011) Excess mortality for patients with residual disease following resection of pituitary adenomas. Pituitary 14(3):276\u2013283","journal-title":"Pituitary"},{"issue":"2","key":"556_CR97","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","volume":"89","author":"IM Holdaway","year":"2004","unstructured":"Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89(2):667\u2013674","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR98","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1210\/jc.2004-2009","volume":"90","author":"JJ Puder","year":"2005","unstructured":"Puder JJ, Nilavar S, Post KD, Freda PU (2005) Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly. J Clin Endocrinol Metab 90:1972\u20131978","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"556_CR99","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/jc.2003-031584","volume":"89","author":"J Ayuk","year":"2004","unstructured":"Ayuk J, Clayton R, Holder G, Sheppard M, Stewart P, Bates A (2004) Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 89(4):1613\u20131617","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1530\/EJE-08-0243","volume":"159","author":"K Tanimoto","year":"2008","unstructured":"Tanimoto K, Hizuka N, Fukuda I, Takano K, Hanafusa T (2008) The influence of age on the GH\u2013IGF1 axis in patients with acromegaly. Eur J Endocrinol 159:375\u2013379","journal-title":"Eur J Endocrinol"},{"key":"556_CR101","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1210\/jc.2004-1974","volume":"90","author":"CL Ronchi","year":"2005","unstructured":"Ronchi CL, Varca V, Giavoli C, Epaminonda P, Beck-Peccoz P, Spada A, Arosio M (2005) Long-term evaluation of postoperative acromegalic patients in remission with previous and newly proposed criteria. J Clin Endocrinol Metab 90:1377\u20131382","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR102","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2265.2007.02769.x","volume":"66","author":"CL Ronchi","year":"2007","unstructured":"Ronchi CL, Arosio M, Rizzo E, Lania AG, Beck-Peccoz P, Spada A (2007) Adequacy of current postglucose GH nadir limit (1 microg\/l) to define long-lasting remission of acromegalic disease. Clin Endocrinol 66:538\u2013542","journal-title":"Clin Endocrinol"},{"key":"556_CR103","unstructured":"Freda PU, Nuruzzaman AT, Post KD (2002) Significance of \u201cabnormal\u201d GH suppression after OGTT with normal IGF-I levels in postoperative patients with acromegaly. In: 84th annual meeting of the endocrine society, San Francisco, CA, June 19\u201322"},{"key":"556_CR104","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1210\/jc.2003-032041","volume":"89","author":"NR Biermasz","year":"2004","unstructured":"Biermasz NR, Dekker FW, van Pereira AM, Thiel SW, Schutte PJ, van Dulken H, Romijn JA, Roelfsema F (2004) Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. J Clin Endocrinol Metab 89:2789\u20132796","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR105","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1210\/jc.2008-0669","volume":"93","author":"SJ Neggers","year":"2008","unstructured":"Neggers SJ, van Aken MO, de Herder WW, Feelders RA, Janssen JA, Badia X, Webb SM, van der Lely AJ (2008) Quality of life in acromegalic patients during long-term somatostatinanalog treatment with and without pegvisomant. J Clin Endocrinol Metab 93:3853\u20133859","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR106","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1210\/jc.2004-2297","volume":"90","author":"NR Biermasz","year":"2005","unstructured":"Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F (2005) Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 90:2731\u20132739","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR107","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/eje.1.01838","volume":"152","author":"IE Bonapart","year":"2005","unstructured":"Bonapart IE, van Domburg R, ten Have SM, de Herder WW, Erdman RA, Janssen JA, van der Lely AJ (2005) The \u2018bio-assay\u2019 quality of life might be a better marker of disease activity in acromegalic patients than serum total IGF-I concentrations. Eur J Endocrinol 152:217\u2013224","journal-title":"Eur J Endocrinol"},{"key":"556_CR108","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1530\/eje.1.02292","volume":"155","author":"SC Hua","year":"2006","unstructured":"Hua SC, Yan YH, Chang TC (2006) Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly. Eur J Endocrinol 155:831\u2013837","journal-title":"Eur J Endocrinol"},{"key":"556_CR109","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2004-1565","volume":"90","author":"SV Rowles","year":"2005","unstructured":"Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ (2005) Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J Clin Endocrinol Metab 90:3337\u20133341","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"556_CR110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11102-009-0191-1","volume":"13","author":"S Melmed","year":"2010","unstructured":"Melmed S, Cook D, Schopohl J, Goth MI, Lam KSL, Marek J (2010) Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotideAutogel therapy: a randomized, placebo-controlled, multicenter study with a 52\u00a0week open extension. Pituitary 13(1):18\u201328","journal-title":"Pituitary"},{"issue":"5\u20136","key":"556_CR111","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cca.2010.11.008","volume":"412","author":"DR Clemmons","year":"2011","unstructured":"Clemmons DR (2011) Clinical laboratory indices in the treatment of acromegaly. Clin Chim Acta 412(5\u20136):403\u2013409","journal-title":"Clin Chim Acta"},{"key":"556_CR112","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2265.2006.02757.x","volume":"66","author":"AA Klaauw van der","year":"2007","unstructured":"van der Klaauw AA, Pereira AM, van Thiel SW, Frolich M, Iranmanesh A, Veldhuis JD, Roelfsema F, Romijn JA (2007) Attenuatedpulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients. Clin Endocrinol 66:489\u2013498","journal-title":"Clin Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-014-0556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-014-0556-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-014-0556-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T23:02:47Z","timestamp":1716505367000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-014-0556-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,5]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1007\/s11102-014-0556-y","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,5]]}}}